Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Clinical trial NCT07565428 · RECRUITING
Trial details
- NCT number
- NCT07565428
- Sponsor
- Minerva Neurosciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2027-12-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.